RES-701-1/endothelin-1 hybrid peptide having a potent binding activity for type B receptor
- 8 July 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (13) , 1715-1720
- https://doi.org/10.1016/s0960-894x(97)00296-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Retraction concerning an endothelin B receptor‐selective antagonist: Urade, Y., Fujitani, Y., Oda, K., Watakabe, T., Umemura, L., Takai, M., Okada, T., Sakata, K. and Karaki, H. (1992) FEBS Lett. 311, 12‐16FEBS Letters, 1994
- RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. II. Determination of the primary sequence.The Journal of Antibiotics, 1994
- RES-701-1,a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. I. Characterization of producing strain, fermentation, isolation, physico-chemical and biological properties.The Journal of Antibiotics, 1994
- Endothelin: progress in pharmacology and physiologyTrends in Pharmacological Sciences, 1993
- Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptorsEndocrinology, 1992
- Cloning and expression of human endothelin‐1 receptor cDNAFEBS Letters, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- ENDOTHELIN AND BRONCHIAL ASTHMAThe Lancet, 1989
- INCREASED PLASMA CONCENTRATIONS OF ENDOTHELIN-1 AND BIG ENDOTHELIN-1 IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1989